ArticleRheumatology international2016

Levels of interleukin-1 beta can predict response to tocilizumab therapy in rheumatoid arthritis: the PETITE (predictors of effectiveness of tocilizumab therapy) study.

Tadashi Okano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.